Vincent Ngouana

Vincent Ngouana


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2025
Verified
Journal Article
Open access
PDF file
VNVincent Ngouana
Vincent Ngouana
JNJoseph Mbaku Ngoumou
Joseph Mbaku Ngoumou
PBPone Kamdem Boniface
Pone Kamdem Boniface
AYAubin Kamche Youbi
Aubin Kamche Youbi
JMJunelle Makemteu
Junelle Makemteu
FBFabrice Fekam Boyom
Fabrice Fekam Boyom
Background: Plasmodium falciparum is responsible for over 90% of malaria cases and the vast majority of malaria-related deaths globally. Oxidative stress, an imbalance between free radicals and antioxidants, plays a key role in the malaria pathogenesis, potentially leading to increased severity of the disease. Growing evidence has shown that Plasmodium species have become resistant to currently available drugs. Thus, there is a pressing need to search for effective treatments against malaria. Because of drug resistance to antimalarial agents, the World Health Organization recommends the use of medicinal plant extracts as alternative therapy for malaria. Combretum rhodanthum is such a plant, which is traditionally used to treat malaria symptoms. Objective: This study sought to investigate the antiplasmodial and antioxidant activities of Combretum rhodanthum extracts. Methods: To this end, the ethanol extraction of Combretum rhodanthum was carried out by maceration. The as-prepared extract was partitioned with hexane, ethyl acetate and n-butanol. The n-butanol fraction, which was found to be the most potent antiplasmodial fraction was chromatographed to yield eight sub-fractions. Antiplasmodial activity was performed in vitro on chloroquino-sensitive (Plasmodium falciparum 3D7; Pf3D7) and multi-resistant (Plasmodium falciparum Dd2; PfDd2) strains of P. falciparum using the SYBR Green-I assay. Antioxidant activity and phytochemical analysis of the most active extracts were performed using standard methods. The acute toxicity of the active extract was studied according to the OECD (Organisation for Economic Co-operation and Development) protocol, guideline number 423. Results: Upon incubation of C. rhodanthum extracts with PfDd2 and Pf3D7, mean inhibitory concentrations ranged from 10.21 to 24.73 μg/mL and from 18.48 to 39.56 μg/mL, respectively. The n-butanol extract, which was chromatographed yielded eight antiplasmodial sub-extracts, the most potent being subfraction [D] (90% ethyl acetate/10% methanol) with IC50 values of 5.30 and 11.21 μg/mL on PfDd2 and Pf3D7, respectively and selectivity for the multidrug-resistant strain (Resistance index<1). Phytochemical analysis of the ethanol extract showed the presence of tannins, terpenoids, phenolic compounds, and glycosides. Upon DPPH and ABTS assays, extracts and fractions scavenged free radicals with mean radical scavenging concentrations (SC50) lower than 39 μg/mL. Moreover, C. rhodanthum extracts reduced Fe3+ into Fe2+ with mean reduction concentration (RS50) less than 26.1 μg/mL. Acute toxicity study revealed no signs of toxicity in Wistar rats at 2000 mg/kg. Conclusion: This novel contribution demonstrates the antiplasmodial and antioxidant activities of Combretum rhodanthum extracts, thus substantiating the ethnomedicinal use of this plant in treating malaria-like symptoms.

29 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
FBFrank Lilian Mahel Batana
Frank Lilian Mahel Batana
VNVincent Ngouana
Vincent Ngouana
EKEugenie Aimée Madiesse Kemgne
Eugenie Aimée Madiesse Kemgne
PBPone Kamdem Boniface
Pone Kamdem Boniface
MNMarius Jaures Tsakem Nangap
Marius Jaures Tsakem Nangap
FBFabrice Fekam Boyom
Fabrice Fekam Boyom
Background: Malaria is a parasitic disease that affects many parts of the globe, especially sub-Saharan Africa. Over time, malaria parasites have become resistant to most antimalarial drugs, including artemisinin. Medicinal plants, which are used in the traditional treatment of malaria can afford effective drugs against this notorious disease. One such plant includes Vernonia blumeoides, which is used in the treatment of parasitic diseases, including malaria. Thus the scientific validation of the use of Vernonia blumeoides in ethnomedicine is of outstanding importance. Objectives: This study sought to investigate the antiplasmodial and antioxidant activity of extracts from Vernonia blumeoides; Methods: Vernonia blumeoides ethanol extract was obtained by maceration, and then subjected to phytochemical screening using standard protocols. The as-prepared extract was partitioned using solvents of increasing polarity to afford hexane, ethyl acetate, n-butanol fractions, and the water residue. The antiplasmodial potential of extract and fractions was determined by the Sybr green method. Antioxidant activity of V. blumeoides extracts was evaluated using DPPH, ABTS and FRAP assays. Cytotoxicity test was performed on murine macrophage Raw cells using the resazurin test; Results: The ethanol extract was obtained as a brown powder and the yield of extraction was found to be 43.95%. The phytochemical screening of this extract revealed the presence of tannins, alkaloids, flavonoids, phenolic compounds, and glycosides. Upon antiplasmodial screening against P. falciparum Dd2 and 3D7, the median inhibitory concentrations (IC50) of extract and fractions from V. blumeoides ranged from 4.70 to >100 µg/ml, with ethyl acetate extract having the lowest IC50 value and highest activity. Vernonia blumeoides extracts exhibited antioxidant activity with median scavenging concentrations ranging from 31.17 to 124.1 µg/mL, 50.84 to 500 µg/mL, and 33.95 to 500 µg/mL for ABTS, DPPH and FRAP assays, respectively. Cytotoxicity test of V. blumeoides extracts on Raw cells revealed non toxicity; Conclusions: This novel contribution demonstrated the antiplasmodial activity of V. blumeoides extracts, thus validating the ethnopharmacological use of this plant in the treatment of malaria symptoms. Nonetheless, in depth studies on the mechanisms of action, in vivo toxicity, as well as pharmacokinetic experiments are warranted for the successful utilization of this plant in ethnomedicine.

12 February 2025 in European Journal of Medicinal Plants
Verified
Journal Article
Open access
PDF file
FBFrank Lilian Mahel Batana
Frank Lilian Mahel Batana
VNVincent Ngouana
Vincent Ngouana
EKEugenie Aimée Madiesse Kemgne
Eugenie Aimée Madiesse Kemgne
PBPone Kamdem Boniface
Pone Kamdem Boniface
MNMarius Jaures Tsakem Nangap
Marius Jaures Tsakem Nangap
FBFabrice Fekam Boyom
Fabrice Fekam Boyom
Background: Malaria is a parasitic disease that affects many parts of the globe, especially sub-Saharan Africa. Over time, malaria parasites have become resistant to most antimalarial drugs, including artemisinin. Medicinal plants, which are used in the traditional treatment of malaria can afford effective drugs against this notorious disease. One such plant includes Vernonia blumeoides, which is used in the treatment of parasitic diseases, including malaria. Thus the scientific validation of the use of Vernonia blumeoides in ethnomedicine is of outstanding importance. Objectives: This study sought to investigate the antiplasmodial and antioxidant activity of extracts from Vernonia blumeoides. Methods: Vernonia blumeoides ethanol extract was obtained by maceration, and then subjected to phytochemical screening using standard protocols. The as-prepared extract was partitioned using solvents of increasing polarity to afford hexane, ethyl acetate, n-butanol fractions, and the water residue. The antiplasmodial potential of extract and fractions was determined by the Sybr green method. Antioxidant activity of V. blumeoides extracts was evaluated using DPPH, ABTS and FRAP assays. Cytotoxicity test was performed on murine macrophage Raw cells using the resazurin test. Results: The ethanol extract was obtained as a brown powder and the yield of extraction was found to be 43.95%. The phytochemical screening of this extract revealed the presence of tannins, alkaloids, flavonoids, phenolic compounds, and glycosides. Upon antiplasmodial screening against P. falciparum Dd2 and 3D7, the median inhibitory concentrations (IC50) of extract and fractions from V. blumeoides ranged from 4.70 to >100 µg/ml, with ethyl acetate extract having the lowest IC50 value and highest activity. Vernonia blumeoides extracts exhibited antioxidant activity with median scavenging concentrations ranging from 31.17 to 124.1 µg/mL, 50.84 to 500 µg/mL, and 33.95 to 500 µg/mL for ABTS, DPPH and FRAP assays, respectively. Cytotoxicity test of V. blumeoides extracts on Raw cells revealed non toxicity. Conclusions: This novel contribution demonstrated the antiplasmodial activity of V. blumeoides extracts, thus validating the ethnopharmacological use of this plant in the treatment of malaria symptoms. Nonetheless, in depth studies on the mechanisms of action, in vivo toxicity, as well as pharmacokinetic experiments are warranted for the successful utilization of this plant in ethnomedicine.